Highly Active Antiretroviral Therapy
Study data from Johns Hopkins University update understanding of highly active antiretroviral therapy
Published in AIDS Weekly, April 19th, 2010
A new study, 'Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells,' is now available. According to recent research published in the Journal of Infectious Diseases, "Treatment of human immunodeficiency virus (HIV) infection with highly active antiretroviral therapy (HAART) is effective but can be associated with toxic effects and is expensive. Other options may be useful for long-term therapy."
"The immunomodulatory antibiotic minocycline could be an effective, low-cost adjunctive treatment to HAART. Minocycline mediated a dose-dependent decrease in single-cycle CXCR4-tropic HIV infection and decreased...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-04-19)
More Articles from AIDS Weekly
- Duke University Medical Center
Scientists identify how a novel class of antibodies inhibits HIV infection - Elsevier Health Sciences
New investigation supports correlation between XMRV and prostate cancer - Antiretrovirals
Researchers from University of California publish new studies and findings in the area of antiretrovirals - Cancer Gene Therapy
Research from National Cancer Institute provide new insights into cancer gene therapy - Disease Progression
Studies from University of Glasgow add new findings in the area of disease progression - Hepatitis B Virus
Researchers from University of Pittsburgh report on findings in hepatitis B virus - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
